Hitachi Launches GenAI Cutting Pharma Docs 50%

🔑 Enhanced Key Takeaways

• •The solution will be integrated into Hitachi’s Lumada portfolio for broader industry use beyond initial Shionogi deployment[1].
• •In Shionogi’s proof-of-concept, the tool reduced clinical trial protocol preparation time by about 20%, in addition to report reductions[1].
• •It processes mixed Japanese and English clinical data to extract, summarize, and generate compliant drafts via an intuitive interface[1].
• •Hitachi and Shionogi signed a basic partnership agreement on January 22, 2026, to co-develop pharma services using data and GenAI[4].

🔮 Future ImplicationsAI analysis grounded in cited sources

⏳ Timeline